Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ambea ABCHIX:AMBEAS 84 EV-to-EBIT is 16.57 as of Jul. 24, 2026, which is 18% below its 10-year median of 20.24. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 84/100 and a GF Value™ of kr125.01 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 469 Healthcare Providers & Services companies, Ambea AB ranks worse than 53.3% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ambea AB's Enterprise Value is kr24,339 Mil.
Ambea AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr1,469 Mil. Therefore, Ambea AB's EV-to-EBIT for today is 16.57.
The historical rank and industry rank for Ambea AB's EV-to-EBIT or its related term are showing as below:
CHIX:AMBEAs'
s EV-to-EBIT Range Over the Past 10 Years
Min: 14.47 Med: 20.24 Max: 36.16
Current: 16.57
During the past 12 years, the highest EV-to-EBIT of Ambea AB was 36.16. The lowest was 14.47. And the median was 20.24.
CHIX:AMBEAs's EV-to-EBIT is ranked worse than 53.3% of 469
companies
in the Healthcare Providers & Services industry
Industry Median: 15.87
vs CHIX:AMBEAs: 16.57
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ambea AB's Enterprise Value for the quarter that ended in Mar. 2026 was kr22,962 Mil.
Ambea AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,469 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB EV-to-EBIT Related Terms
Ambea AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Ambea AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:AMBEAS vs HCA, THC, DVA: EV-to-EBIT Comparison
For the Medical Care Facilities subindustry, Ambea AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ambea AB's EV-to-EBIT falls into.
Ambea AB's current Enterprise Value is kr24,339 Mil.
Ambea AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,469 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambea AB (CHIX:AMBEAS) has a EV-to-EBIT of 16.57 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ambea AB and its competitors. This is 18% below median its historical median of 20.24. Over the past decade, Ambea AB's EV-to-EBIT has ranged from 14.47 to 36.16. According to the industry distribution chart, Ambea AB ranks #250 out of 469 companies in the Healthcare Providers & Services industry, placing it in the top 53.3%.
Is Ambea AB's EV-to-EBIT too high?
Ambea AB's current EV-to-EBIT of 16.57 is 18% below median its 10-year median of 20.24. Over the past 10 years, this metric has ranged from a low of 14.47 to a high of 36.16. The Healthcare Providers & Services industry median EV-to-EBIT is 15.87. Ambea AB's value of 16.57 is 4.4% above this industry median. Based on the distribution chart, Ambea AB ranks #250 out of 469 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ambea AB has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #250 out of 469 companies for EV-to-EBIT. This places Ambea AB in the lower half of its industry. The industry median EV-to-EBIT is 15.87. Ambea AB's value of 16.57 is 4.4% above this benchmark. Historically, Ambea AB's own EV-to-EBIT has ranged from 14.47 to 36.16 over the past decade. While the company's 10-year median is 20.24 vs. the industry median of 15.87, Ambea AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.87, based on 469 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current EV-to-EBIT of 16.57 is 4.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current EV-to-EBIT is 16.57, which is 18% below median its own 10-year median of 20.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr125.01, compared to a current price of kr144.20 — trading 15.4% above its estimated fair value. The current EV-to-EBIT is 16.57, which is 18% below median its 10-year median of 20.24 and 4.4% above the Healthcare Providers & Services industry median of 15.87. Ambea AB's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current EV-to-EBIT is 16.57 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 15.4% above its estimated GF Value™ of kr125.01.
GuruFocus considers Ambea AB to be Modestly Overvalued.
Key valuation signals for CHIX:AMBEAS:
EV-to-EBIT: 16.57 (18% below median its 10-year median of 20.24)
GF Value™: kr125.01 vs. price of kr144.20 (15.4% above fair value)
Industry Position: 4.4% above the Healthcare Providers & Services median (#250 of 469)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
84GF Score
Get the complete analysis for CHIX:AMBEAS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
